Published by Josh White on 17th February 2021
(Sharecast News) - Clinical stage drug development company Evgen Pharma said on Wednesday that a total of 102 patients had been recruited and randomised to the 'STAR', or 'SFX-01 Treatment for Acute Respiratory infections', trial.
URL: http://www.digitallook.com/dl/news/story/31652044/...